| Item |
Information |
|
Drug Groups
|
approved |
|
Description
|
A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections. [PubChem] |
| Indication |
For the treatment of bacterial infections caused by susceptible microorganisms. |
| Pharmacology |
Cefonicid is a second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections. |
| Affected Organisms |
| • |
Enteric bacteria and other eubacteria |
|
| Biotransformation |
Not metabolized. |
| Half Life |
4.5 hours |
| Protein Binding |
98% bound to plasma proteins. |